Firms
Theme

WSBC

WesBanco Inc · NASDAQ

News

3 latest

Zacks Investment Research

WesBanco (WSBC) Reports Q3 Earnings: What Key Metrics Have to Say

WesBanco reported Q3 2026 revenue of $272.74 million, up 4.3% year-over-year but missing consensus estimates by 1.3%. EPS of $0.89 beat expectations by 2.3%, though down from $0.94 a year ago.

Zacks Investment Research

WesBanco (WSBC) Q3 Earnings Surpass Estimates

WesBanco (WSBC) reported Q3 2026 earnings of $0.89 per share, beating consensus estimates of $0.87, but missed revenue expectations at $272.74 million versus the estimate of $276.32 million. The stock has outperformed the S&P 500 by 50 basis points year-to-date. Despite the earnings beat, the company maintains a Zacks Rank #3 (Hold) rating due to mixed estimate revision trends, suggesting near-term performance in line with the market.

Zacks Investment Research

Earnings Preview: WesBanco (WSBC) Q3 Earnings Expected to Decline

WesBanco is expected to report declining earnings despite revenue growth for Q3 2026, with an Earnings ESP of -0.61% and Zacks Rank #3 making an earnings beat unlikely. Hancock Whitney is projected to show stronger earnings growth of 10.7% year-over-year, but similarly faces a negative Earnings ESP of -0.20% despite its Zacks Rank #2 rating, making conclusive earnings beat predictions difficult for both banks.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $WSBC · 0 threads

Sign in to post on $WSBC

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev